Trial
NCT00848107
Open-Label Study of Oral Treprostinil in Digital Ulcers
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
United Therapeutics
Collaborators
—
Condition
Systemic Sclerosis
Intervention
treprostinil diethanolamine
Why stopped
The TDE-DU-202 extension study was discontinued after the randomized, placebo-controlled TDE-DU-201 study did not meet its primary efficacy objective.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-18